The global animal placental protein market size was valued at US$ 551.9 million in 2023 and is projected to reach US$ 808.1 million by 2030, at a CAGR of 5.6% from 2023 to 2030.
The market is segmented by type, origin, application, and region. By type, the market is segmented into hydrolyzed and non-hydrolyzed. The hydrolyzed segment is projected to grow at a faster CAGR during the forecast period due to its increased solubility and absorption.
Animal Placental Protein Market Regional Insights
- North America is the largest market for animal placental protein, accounting for over 35% of the global market share in 2022. The high demand for animal placental protein in North America is attributed to the increasing use of placental protein in cosmetics, dietary supplements, and other health and wellness products.
- Europe is the second largest market for animal placental protein, accounting for over 25% of the global market share in 2022. The high demand for animal placental protein in Europe is attributed to the increasing awareness about the benefits of placental protein and the growing popularity of natural and organic products.
- Asia-Pacific is the third largest market for animal placental protein, accounting for over 20% of the global market share in 2022. The high demand for animal placental protein in Asia-Pacific is attributed to the growing population and the increasing disposable income of consumers.
Figure 1. Global Animal Placental Protein Market Share (%), by Region, 2023
Animal Placental Protein Market Drivers
- Increasing demand for high-quality protein ingredients: Animal placental proteins are rich in essential amino acids, growth factors, and bioactive peptides. These components make them valuable as nutritional supplements, functional food ingredients, and additives in various industries, including pharmaceuticals and cosmetics.
- Growing awareness of the health benefits: Research and studies had been highlighting the potential health benefits of animal placental proteins. They were believed to support cell regeneration, wound healing, immune function, and anti-aging properties, among others. As consumers became more health-conscious and sought natural remedies, the demand for such products increased.
- Expanding applications in pharmaceuticals: Animal placental proteins had been used in the development of novel pharmaceutical drugs and therapeutic treatments. Their ability to promote tissue repair, regeneration, and wound healing made them attractive candidates for use in advanced medical applications.
- Rising demand in the cosmetics industry: Cosmetic companies were exploring the incorporation of animal placental proteins into skincare products. These proteins were believed to enhance collagen production, improve skin elasticity, and reduce signs of aging, making them sought-after ingredients in the beauty and personal care sector.
Animal Placental Protein Market Opportunities
- Expansion of product applications: Animal placental proteins had shown promise in various industries, including pharmaceuticals, cosmetics, and functional foods. There was an opportunity for further research and development to explore new applications, such as in regenerative medicine, nutraceuticals, and veterinary medicine.
- Geographic market expansion: The market for animal placental proteins was not evenly distributed across the globe. There were opportunities for companies to expand their presence into new regions and tap into emerging markets where awareness and demand for such products were growing.
- Customized product development: Consumers were increasingly seeking personalized and tailored products to meet their specific needs and preferences. Developing customizable animal placental protein products based on individual requirements could open up new market segments and attract a broader customer base.
- Collaborations and partnerships: Collaborating with research institutions, universities, and industry players could foster innovation and accelerate product development. Partnerships in manufacturing, distribution, and marketing could also enhance market reach and visibility.
Animal Placental Protein Market Report Coverage
| Report Coverage |
Details |
| Base Year: |
2022 |
Market Size in 2023: |
US$ 551.9 Mn |
| Historical Data for: |
2018 to 2021 |
Forecast Period: |
2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: |
5.6% |
2030 Value Projection: |
US$ 808.1 Mn |
| Geographies covered: |
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East & Africa: GCC Countries, Israel, South Africa, North Africa, and Central Africa and Rest of Middle East
|
| Segments covered: |
- By Product Type: Animal Placental Protein Extracts, Animal Placental Protein Powders, Animal Placental Protein Capsules/Tablets, Animal Placental Protein Injections
- By Application: Pharmaceuticals (including human and veterinary medicine), Cosmetics and Personal Care Products, Nutraceuticals and Dietary Supplements, Research and Biotechnology
- By Animal Source: Bovine (cow), Porcine (pig), Ovine (sheep), Equine (horse), Others (e.g., deer, kangaroo)
- By End user: Pharmaceutical Companies, Cosmetics and Personal Care Companies, Nutraceutical and Dietary Supplement Manufacturers, Research Institutions and Laboratories
- By Distribution Channel: Direct Sales (B2B), Retail Sales (B2C), Online Retail
|
| Companies covered: |
Sigma-Aldrich Corporation (Now part of Merck KGaA), Biotain Pharma Co., Ltd., New Zealand Health Food Company Limited, XABC Biotech Co., Ltd., BIOFAC A/S, Chaitanya Biologicals Pvt. Ltd., Serolab SA, Auckland BioSciences Limited, ANZCO Foods Limited & Biocontinental Co., Ltd.
|
| Growth Drivers: |
- Increasing demand for high-quality protein ingredient
- Growing awareness of the health benefits
- Expanding applications in pharmaceuticals
- Rising demand in the cosmetics industry
|
| Restraints & Challenges: |
- Ethical and Moral Concerns
- Regulatory Hurdles
- Limited Awareness and Knowledge
- High Production Costs
|
Animal Placental Protein Market Trends
- Increasing Demand for Natural and Bioactive Ingredients: Consumers were increasingly seeking natural and bioactive ingredients in their food, supplements, and personal care products. Animal placental proteins, being derived from natural sources, were gaining popularity due to their perceived health benefits and potential for supporting overall well-being.
- Rise in Nutraceutical and Functional Food Products: The demand for nutraceuticals and functional foods had been on the rise, driven by consumers' focus on preventive healthcare and wellness. Animal placental proteins were finding applications in these products due to their high nutritional value and reported health benefits.
- Growing Interest in Regenerative Medicine: Animal placental proteins, with their ability to promote tissue repair and regeneration, were garnering attention in the field of regenerative medicine. Researchers and medical professionals were exploring their potential for wound healing and tissue engineering applications.
- Advancements in Extraction and Processing Technologies: Technological advancements in protein extraction and processing were leading to improved yields and higher purity of animal placental proteins. These developments were making the production process more efficient and cost-effective.
Animal Placental Protein Market Restraints
- Ethical and Moral Concerns: The use of animal-derived products, including animal placental proteins, raised ethical and moral concerns among some consumers and advocacy groups. This could lead to opposition and potential consumer backlash, affecting market acceptance.
- Regulatory Hurdles: The animal placental protein market was subject to regulatory oversight and compliance requirements, especially concerning the sourcing, extraction, and processing of these proteins. Adherence to diverse and evolving regulations in different regions posed challenges for market players.
- Limited Awareness and Knowledge: Despite growing interest, there was still limited awareness and knowledge among consumers and healthcare professionals about animal placental proteins and their potential benefits. Lack of understanding could impact consumer adoption and market penetration.
- High Production Costs: The production of animal placental proteins involved complex extraction and purification processes, which could be costly. The high production costs might result in elevated product prices, potentially limiting market accessibility for some consumers.
Recent Developments
New product launches
- In 2021, Japan Bio Products GmbH launched a new line of placental protein supplements. The supplements are made from high-quality pig placenta and are said to help improve skin health, boost energy levels, and reduce stress.
- In 2022, R&D Systems, Inc. launched a new line of placental protein antibodies. The antibodies are used in research and diagnostic applications.
- In 2023, Abcam plc launched a new line of placental protein ELISA kits. The kits are used to measure the levels of placental protein in blood or tissue samples.
Acquisition and partnerships
- In 2021, China Bio-Technology International Holdings Ltd. acquired New Zealand-based PlacentalCare for $30 million. PlacentalCare is a leading supplier of placental protein products for the health and beauty industry.
- In 2022, Japan-based Chiyoda Pharmaceutical Industry Co., Ltd. acquired South Korea-based Seokyung Biopharm Co., Ltd. for $50 million. Seokyung Biopharm is a leading supplier of placental protein products for the pharmaceutical industry.
- In 2023, US-based Placenta Sciences, Inc. partnered with Swiss-based Lonza Group AG to develop and commercialize placental protein products for the medical and wellness markets.
Figure 2. Global Animal Placental Protein Market Share (%), by Animal Source, 2023
Top companies in Animal Placental Protein Market
- Sigma-Aldrich Corporation (Now part of Merck KGaA)
- Biotain Pharma Co., Ltd.
- New Zealand Health Food Company Limited
- XABC Biotech Co., Ltd.
- BIOFAC A/S
- Chaitanya Biologicals Pvt. Ltd.
- Serolab SA
- Auckland BioSciences Limited
- ANZCO Foods Limited
- Biocontinental Co., Ltd.
*Definition: The Animal Placental Protein market refers to the industry that involves the extraction, production, and commercialization of proteins obtained from animal placental tissues. These proteins are utilized in various applications, such as skincare, cosmetics, pharmaceuticals, nutritional supplements, and regenerative medicine, due to their potential benefits for tissue regeneration and overall health.
U.S.: 
U.K. : 
India :